Verastem, Inc. (VSTM)
6.14
+0.48
(+8.48%)
USD |
NASDAQ |
Apr 14, 16:00
6.14
0.00 (0.00%)
After-Hours: 18:14
Verastem Cash from Investing (TTM) : -9.624M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Johnson & Johnson | -23.59B |
| Merck & Co., Inc. | -13.74B |
| Altimmune, Inc. | -132.47M |
| Ocugen, Inc. | -0.311M |
| Xilio Therapeutics, Inc. | -0.518M |